Zika en Panamá y Latinoamérica: Aspectos clínicos y moleculares de una problemática emergente
[Zika in Panama and Latin America: Clinical and molecular aspects of an emerging problem.]Jorge David Mendez-Rios1, Sandra López-Vergès1, José Suarez1, Brechla Moreno1, Claude Vergès de López1, David E Méndez Dutary1, Dora Estripeaut1, José González-Santamaría1, Gloriela de Villareal1, Anayansi Valderrama1, Lorenzo Cáceres1, Nestor Sosa1
Descargas
Resumen
El propósito de esta revisión es presentar al equipo de salud latinoamericano y de la región del caribe un panorama de la situación actual con el virus Zika (ZIKAV), y al mismo tiempo, proveer conocimiento clínica y molecular relevante para enfrentar este problema emergente. Esperamos que esta revisión tenga un impacto positivo en el diagnóstico, vigilancia, y tratamiento de esta enfermedad viral, especialmente en comunidades endémicas, como parte de un esfuerzo colectivo para enfrentar este virus. Este manuscrito será distribuido electrónicamente y físicamente como una iniciativa de salud pública y epidemiologica.
Abstract
The purpose of this review is to provide Latin America's and the region's healthcare professionals with an overview of the current situation related to Zika virus (ZIKAV), and at the same time, to provide relevant clinical and molecular knowledge against this emerging problem. We expect to have a positive impact in diagnostic, surveillance and treatment of this viral disease, specially in those endemic communities, as part of a collective effort against the virus. This review will be distributed as hard-copy and online as a public health and epidemiological initiative.
Citas
[1] Gautret, P. and F. Simon, Dengue, chikungunya and Zika and mass gatherings: What happened in Brazil, 2014. Travel Med Infect Dis, 2015.
[2] Fauci, A.S. and D.M. Morens, Zika Virus in the Americas - Yet Another Arbovirus Threat. N Engl J Med, 2016.
[3] Duffy, M.R., et al., Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med, 2009. 360(24): p. 2536-43.
[4] Chen, L.H. and D.H. Hamer, Zika Virus: Rapid Spread in the Western Hemisphere. Ann Intern Med, 2016.
[5] MINSA, Panamá declara Alerta Sanitaria Nacional por el virus zika. Alerta Sanitaria, 17 de febrero, 2016.
[6] Gatherer, D. and A. Kohl, Zika virus: a previously slow pandemic spreads rapidly through the Americas. J Gen Virol, 2015.
[7] Baronti, C., et al., Complete coding sequence of zika virus from a French polynesia outbreak in 2013. Genome Announc, 2014. 2(3).
[8] Enfissi, A., et al., Zika virus genome from the Americas. Lancet, 2016. 387(10015): p. 227-8.
[9] Hamel, R., et al., Biology of Zika Virus Infection in Human Skin Cells. J Virol, 2015. 89(17): p. 8880-96.
[10] Wolfe, N.D., et al., Sylvatic transmission of arboviruses among Bornean orangutans. Am J Trop Med Hyg, 2001. 64(5-6): p. 310-6.
[11] McCarthy, M., Zika virus was transmitted by sexual contact in Texas, health officials report. BMJ, 2016. 352: p. i720.
[12] Petersen EE, S.J., Meaney-Delman, D, et al., Interim Guidelines for Pregnant Women During a Zika Virus Outbreak. MMWR Morb Mortal Wkly Rep, (2016;65:30–33.).
[13] OPS/OMS, Infección por Zika. Actualización Epidemiológica Oct 2015.
[14] Bisset, J.A., M.M. Rodriguez, and L. Caceres, [Levels of resistance to insecticides and their mechanisms in 2 strains of Aedes aegypti from Panama]. Rev Cubana Med Trop,2003,55(3): p.191-5.
[15] Pimsamarna S, e.a., Detection of insecticide resistance in Aedes aegypti to organophosphate and synthetic pyrethroid compounds in the north-east of Thailand. Dengue Bulletin, 2009. 33.
[16] Marcombe, S., et al., Exploring the molecular basis of insecticide resistance in the dengue vector Aedes aegypti: a case study in Martinique Island (French West Indies). BMC Genomics, 2009. 10: p. 494.
[17] Teurlai, M., et al., Socio-economic and Climate Factors Associated with Dengue Fever Spatial Heterogeneity: A Worked Example in New Cale-donia. PLoS Negl Trop Dis, 2015. 9(12): p.e0004211.
[18] Pozo E, e.a., Factores asociados a la infestación intradomiciliaria por Aedes aegypti en el distrito de Tambogrande, Piura 2004. Rev Peru Med Exp Salud Pública, 2007. 24(2): p. 144-51.
[19] Gomez-Dantes, H., et al., [Integrated prevention and control strategy for dengue in Mesoamerica]. Salud Publica Mex, 2011. 53 Suppl 3: p. S349-57.
[20] McMichael, A.J., R.E. Woodruff, and S. Hales, Climate change and human health: present and future risks. Lancet, 2006. 367(9513): p. 859-69.
[21] Fredericks, A.C. and A. Fernandez-Sesma, The burden of dengue and chikungunya worldwide: implications for the southern United States and California. Ann Glob Health, 2014. 80(6): p. 466-75.
[22] Moreira, L.A., et al., A Wolbachia symbiont in Aedes aegypti limits infection with dengue, Chikungunya, and Plasmodium. Cell, 2009. 139(7): p. 1268-78.
[23] Mendez Galvan J, e.a., Detection of Aedes aegypti Mosquitoes Infected with Dengue Virus as a Complementary Method for Increasing the Sensitivity of Surveillance: Identification of Serotypes 1, 2, and 4 by RT-PCR in Quintana Roo, Mexico. South-western Enthomologist, 2014. 39(2): p. 307-316.
[24] CDC, Clinical Evaluation & Diseases for Health Care providers. 2016.
[25] CDC, Revised diagnostic testing for Zika, chikungunya, and dengue viruses in US Public Health Laboratories Memorandum, 7 Feb, 2016.
[26] Lanciotti, R.S., et al., Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis, 2007. 13(5): p. 764-7.
[27] Ayers, M., et al., A single tube RT-PCR assay for the detection of mosquito-borne flaviviruses. J Virol Methods, 2006. 135(2): p. 235-9.
[28] CDC - Division of Vector-Borne Diseases, A.D.a.d.B., Updated diagnostics testing for Zika, chikungunya, and dengue viruses in US Public Health Laboratories. January 13, 2016.
[29] Grupo Transmisibles, E.V.E.-M.C., Protocolo de Vigilancia en Salud Pública - Enfermedad por Virus Zika. Enero 2016.
[30] Epidemiología, M.d.S.P.y.A.s.C.N.d., Protocolo de vigilancia epidemiológica enfermedad febril por virus Zika. Julio 2015.
[31] Salud, S.d., Infección por virus Zika en México. Febrero 2016.
[32] Euroimmune, U., New Tests Overcome Problems of Flavivirus Cross Reactivity. Press release, 2015.
[33] Oliveira Melo, A.S., et al., Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol, 2016. 47(1): p. 6-7.
[34] Rodriguez-Morales, A.J., Zika and microcephaly in Latin America: An emerging threat for pregnant travelers? Travel Med Infect Dis, 2016.
[35] Schuler-Faccini, L., et al., Possible Association Between Zika Virus Infection and Microcephaly - Brazil, 2015. MMWR Morb Mortal Wkly Rep, 2016. 65(3): p. 59-62.
[36] Tetro, J.A., Zika and microcephaly: causation, correlation, or coincidence? Microbes Infect, 2016.
[37] Boadle, A., Brazil says Zika-linked microcephaly cases rise to 4,074. Reuters, Feb 2, 2016.
[38] Microcefalias, C.d.o.d.e.e.S.P.s., Informe Epidemiológico No13. COES - Microcefalia, 13 de febrero, 2016.
[39] Olshansky, A., Diagnosis and treatment of guillain-barre syndrome. Virtual Mentor, 2007. 9(8): p. 552-4.
[40] Hosokawa, M., et al., Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barre syndrome by quantitative determination of TDP-43 in cerebrospinal fluid. Int J Neurosci, 2014. 124(5): p. 344-9.
[41] OMS, Guillain-Barré syndrome – El Salvador. Emergencies preparedness, response 21 January 2016
[42] Ventura, C.V., et al., Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet, 2016. 387(10015): p. 228.
[43] OPS/OMS, Virus del Zika – Incidencia y tendencias. Actualización Epidemiológica, 3 de marzo, 2016.
[44] Diamond, M.S., et al., Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol, 2003. 16(3): p. 259-78.
[45] Bell, T.M., E.J. Field, and H.K. Narang, Zika virus infection of the central nervous system of mice. Arch Gesamte Virusforsch, 1971. 35(2): p. 183-93.
[46] Zammarchi, L., et al., Zika virus infection in a traveller returning to Europe from Brazil, March 2015. Euro Surveill, 2015. 20(23).
[47] Lanciotti, R., et. al, Genetic and serologic properties of Zika Virus associated with an epidemic, Yap State, Micronesia, 2007. Emerging Infectious Diseases, Aug 2008.
[48] Vogel, G., EMERGING DISEASES. A race to explain Brazil's spike in birth defects. Science, 2016. 351(6269): p. 110-1.
[49] ECDC, Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome.
[50] Brasil, M.d.S.-G.d., Ministério da Saúde atualiza casos suspeitos de microcefalia. Enero 2016.
Licencia
Derechos de autor 2016 Revista Médica de Panamá - ISSN 2412-642X
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Derechos autoriales y de reproducibilidad. La Revista Médica de Panama es un ente académico, sin fines de lucro, que forma parte de la Academia Panameña de Medicina y Cirugía. Sus publicaciones son de tipo acceso gratuito de su contenido para uso individual y académico, sin restricción. Los derechos autoriales de cada artículo son retenidos por sus autores. Al Publicar en la Revista, el autor otorga Licencia permanente, exclusiva, e irrevocable a la Sociedad para la edición del manuscrito, y otorga a la empresa editorial, Infomedic International Licencia de uso de distribución, indexación y comercial exclusiva, permanente e irrevocable de su contenido y para la generación de productos y servicios derivados del mismo. En caso que el autor obtenga la licencia CC BY, el artículo y sus derivados son de libre acceso y distribución.
